The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N''-[2-(1,3-benzothiazol-2-ylthio)-6-fluoro-2,3-dihydro-1H-inden-1-ylidene]carbonohydrazonic diamide dihydrochloride ID: ALA3217122
PubChem CID: 44225254
Max Phase: Preclinical
Molecular Formula: C17H16Cl2FN5S2
Molecular Weight: 371.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cl.Cl.NC(N)=N/N=C1\c2cc(F)ccc2CC1Sc1nc2ccccc2s1
Standard InChI: InChI=1S/C17H14FN5S2.2ClH/c18-10-6-5-9-7-14(15(11(9)8-10)22-23-16(19)20)25-17-21-12-3-1-2-4-13(12)24-17;;/h1-6,8,14H,7H2,(H4,19,20,23);2*1H/b22-15+;;
Standard InChI Key: XCQPWDONYQZHLM-IFGMWRHRSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
11.8497 1.2485 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0872 0.0382 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.8208 1.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1876 2.6658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3007 1.5139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5811 2.9807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2685 3.6962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2157 5.1993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5164 5.9854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8290 5.2698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8731 3.7507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3156 0.4118 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7802 0.7394 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7970 -0.3646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9680 -0.1026 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4386 -1.5098 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8518 5.8974 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.3497 1.2485 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3 4 1 0
13 16 1 0
15 14 1 0
14 12 1 0
4 7 2 0
2 3 2 0
15 16 2 0
6 5 2 0
16 17 1 0
7 8 1 0
17 18 2 0
8 9 1 0
18 19 1 0
9 10 2 0
19 20 2 0
20 15 1 0
10 6 1 0
14 21 2 0
5 2 1 0
21 22 1 0
9 11 1 0
22 23 2 0
6 7 1 0
23 24 1 0
11 12 1 0
23 25 1 0
12 13 1 0
19 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 371.47Molecular Weight (Monoisotopic): 371.0675AlogP: 3.13#Rotatable Bonds: 3Polar Surface Area: 89.65Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.87CX LogP: 3.56CX LogD: 3.45Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.42Np Likeness Score: -1.28
References 1. Zhang R, Dong J, Xu YG, Hua WY, Wen N, You QD.. (2009) Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives., 44 (9): [PMID:19482383 ] [10.1016/j.ejmech.2009.04.036 ]